Global Veterinary Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to APO Research, The global Veterinary Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Veterinary Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.
The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to APO Research, The global Veterinary Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Veterinary Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.
The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken Laboratories
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal Health
- MEVAC
- Biovac
- Atafen
- Dyntec
- BioTestLab
- RVSRI
- Medion
- Live Attenuated Vaccines
- Inactivated Vaccines
- Others
- Livestock
- Swine
- Chicken
- Dog & Cat
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Veterinary Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Veterinary Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Veterinary Vaccine Market by Type
1.3.1 Live Attenuated Vaccines
1.3.2 Inactivated Vaccines
1.3.3 Others
1.4 Global Veterinary Vaccine Market Size by Type
1.4.1 Global Veterinary Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Veterinary Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Veterinary Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Veterinary Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Veterinary Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Veterinary Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Veterinary Vaccine Industry Trends
2.2 Veterinary Vaccine Industry Drivers
2.3 Veterinary Vaccine Industry Opportunities and Challenges
2.4 Veterinary Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Veterinary Vaccine Revenue (2019-2024)
3.2 Global Top Players by Veterinary Vaccine Sales (2019-2024)
3.3 Global Top Players by Veterinary Vaccine Price (2019-2024)
3.4 Global Veterinary Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Veterinary Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Veterinary Vaccine Company, Product Type & Application
3.7 Global Veterinary Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Veterinary Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Veterinary Vaccine Tier 1, Tier 2, and Tier
4 VETERINARY VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Veterinary Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Veterinary Vaccine Historic Market Size by Region
4.2.1 Global Veterinary Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Veterinary Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Veterinary Vaccine Forecasted Market Size by Region
4.3.1 Global Veterinary Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Veterinary Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 VETERINARY VACCINE BY APPLICATION
5.1 Veterinary Vaccine Market by Application
5.1.1 Livestock
5.1.2 Swine
5.1.3 Chicken
5.1.4 Dog & Cat
5.1.5 Others
5.2 Global Veterinary Vaccine Market Size by Application
5.2.1 Global Veterinary Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Veterinary Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Veterinary Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Veterinary Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Veterinary Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Veterinary Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Merck
6.1.1 Merck Comapny Information
6.1.2 Merck Business Overview
6.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Veterinary Vaccine Product Portfolio
6.1.5 Merck Recent Developments
6.2 Zoetis
6.2.1 Zoetis Comapny Information
6.2.2 Zoetis Business Overview
6.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Veterinary Vaccine Product Portfolio
6.2.5 Zoetis Recent Developments
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Comapny Information
6.3.2 Boehringer Ingelheim Business Overview
6.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments
6.4 Ceva
6.4.1 Ceva Comapny Information
6.4.2 Ceva Business Overview
6.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Veterinary Vaccine Product Portfolio
6.4.5 Ceva Recent Developments
6.5 CAHIC
6.5.1 CAHIC Comapny Information
6.5.2 CAHIC Business Overview
6.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CAHIC Veterinary Vaccine Product Portfolio
6.5.5 CAHIC Recent Developments
6.6 HVRI
6.6.1 HVRI Comapny Information
6.6.2 HVRI Business Overview
6.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HVRI Veterinary Vaccine Product Portfolio
6.6.5 HVRI Recent Developments
6.7 Ringpu Biology
6.7.1 Ringpu Biology Comapny Information
6.7.2 Ringpu Biology Business Overview
6.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
6.7.5 Ringpu Biology Recent Developments
6.8 Yebio
6.8.1 Yebio Comapny Information
6.8.2 Yebio Business Overview
6.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Yebio Veterinary Vaccine Product Portfolio
6.8.5 Yebio Recent Developments
6.9 DHN
6.9.1 DHN Comapny Information
6.9.2 DHN Business Overview
6.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 DHN Veterinary Vaccine Product Portfolio
6.9.5 DHN Recent Developments
6.10 WINSUN
6.10.1 WINSUN Comapny Information
6.10.2 WINSUN Business Overview
6.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 WINSUN Veterinary Vaccine Product Portfolio
6.10.5 WINSUN Recent Developments
6.11 Elanco
6.11.1 Elanco Comapny Information
6.11.2 Elanco Business Overview
6.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Elanco Veterinary Vaccine Product Portfolio
6.11.5 Elanco Recent Developments
6.12 Virbac
6.12.1 Virbac Comapny Information
6.12.2 Virbac Business Overview
6.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Virbac Veterinary Vaccine Product Portfolio
6.12.5 Virbac Recent Developments
6.13 Jinyu Bio-Technology
6.13.1 Jinyu Bio-Technology Comapny Information
6.13.2 Jinyu Bio-Technology Business Overview
6.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
6.13.5 Jinyu Bio-Technology Recent Developments
6.14 ChengDu Tecbond
6.14.1 ChengDu Tecbond Comapny Information
6.14.2 ChengDu Tecbond Business Overview
6.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
6.14.5 ChengDu Tecbond Recent Developments
6.15 CAVAC
6.15.1 CAVAC Comapny Information
6.15.2 CAVAC Business Overview
6.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CAVAC Veterinary Vaccine Product Portfolio
6.15.5 CAVAC Recent Developments
6.16 Kyoto Biken Laboratories
6.16.1 Kyoto Biken Laboratories Comapny Information
6.16.2 Kyoto Biken Laboratories Business Overview
6.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
6.16.5 Kyoto Biken Laboratories Recent Developments
6.17 FATRO
6.17.1 FATRO Comapny Information
6.17.2 FATRO Business Overview
6.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 FATRO Veterinary Vaccine Product Portfolio
6.17.5 FATRO Recent Developments
6.18 Vaksindo
6.18.1 Vaksindo Comapny Information
6.18.2 Vaksindo Business Overview
6.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Vaksindo Veterinary Vaccine Product Portfolio
6.18.5 Vaksindo Recent Developments
6.19 Bio-Labs
6.19.1 Bio-Labs Comapny Information
6.19.2 Bio-Labs Business Overview
6.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
6.19.5 Bio-Labs Recent Developments
6.20 Avimex Animal Health
6.20.1 Avimex Animal Health Comapny Information
6.20.2 Avimex Animal Health Business Overview
6.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
6.20.5 Avimex Animal Health Recent Developments
6.21 MEVAC
6.21.1 MEVAC Comapny Information
6.21.2 MEVAC Business Overview
6.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 MEVAC Veterinary Vaccine Product Portfolio
6.21.5 MEVAC Recent Developments
6.22 Biovac
6.22.1 Biovac Comapny Information
6.22.2 Biovac Business Overview
6.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Biovac Veterinary Vaccine Product Portfolio
6.22.5 Biovac Recent Developments
6.23 Atafen
6.23.1 Atafen Comapny Information
6.23.2 Atafen Business Overview
6.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Atafen Veterinary Vaccine Product Portfolio
6.23.5 Atafen Recent Developments
6.24 Dyntec
6.24.1 Dyntec Comapny Information
6.24.2 Dyntec Business Overview
6.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Dyntec Veterinary Vaccine Product Portfolio
6.24.5 Dyntec Recent Developments
6.25 BioTestLab
6.25.1 BioTestLab Comapny Information
6.25.2 BioTestLab Business Overview
6.25.3 BioTestLab Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.25.4 BioTestLab Veterinary Vaccine Product Portfolio
6.25.5 BioTestLab Recent Developments
6.26 RVSRI
6.26.1 RVSRI Comapny Information
6.26.2 RVSRI Business Overview
6.26.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.26.4 RVSRI Veterinary Vaccine Product Portfolio
6.26.5 RVSRI Recent Developments
6.27 Medion
6.27.1 Medion Comapny Information
6.27.2 Medion Business Overview
6.27.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Medion Veterinary Vaccine Product Portfolio
6.27.5 Medion Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Veterinary Vaccine Sales by Country
7.1.1 North America Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Veterinary Vaccine Sales by Country (2019-2024)
7.1.3 North America Veterinary Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Veterinary Vaccine Market Size by Country
7.2.1 North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Veterinary Vaccine Market Size by Country (2019-2024)
7.2.3 North America Veterinary Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Veterinary Vaccine Sales by Country
8.1.1 Europe Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Veterinary Vaccine Sales by Country (2019-2024)
8.1.3 Europe Veterinary Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Veterinary Vaccine Market Size by Country
8.2.1 Europe Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Veterinary Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Veterinary Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Veterinary Vaccine Sales by Country
9.1.1 Asia-Pacific Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Veterinary Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Veterinary Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Veterinary Vaccine Market Size by Country
9.2.1 Asia-Pacific Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Veterinary Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Veterinary Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Veterinary Vaccine Sales by Country
10.1.1 Latin America Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Veterinary Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Veterinary Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Veterinary Vaccine Market Size by Country
10.2.1 Latin America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Veterinary Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Veterinary Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Veterinary Vaccine Sales by Country
11.1.1 Middle East and Africa Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Veterinary Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Veterinary Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Veterinary Vaccine Market Size by Country
11.2.1 Middle East and Africa Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Veterinary Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Veterinary Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Veterinary Vaccine Value Chain Analysis
12.1.1 Veterinary Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Veterinary Vaccine Production Mode & Process
12.2 Veterinary Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Veterinary Vaccine Distributors
12.2.3 Veterinary Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Veterinary Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Veterinary Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Veterinary Vaccine Market by Type
1.3.1 Live Attenuated Vaccines
1.3.2 Inactivated Vaccines
1.3.3 Others
1.4 Global Veterinary Vaccine Market Size by Type
1.4.1 Global Veterinary Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Veterinary Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Veterinary Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Veterinary Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Veterinary Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Veterinary Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Veterinary Vaccine Industry Trends
2.2 Veterinary Vaccine Industry Drivers
2.3 Veterinary Vaccine Industry Opportunities and Challenges
2.4 Veterinary Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Veterinary Vaccine Revenue (2019-2024)
3.2 Global Top Players by Veterinary Vaccine Sales (2019-2024)
3.3 Global Top Players by Veterinary Vaccine Price (2019-2024)
3.4 Global Veterinary Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Veterinary Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Veterinary Vaccine Company, Product Type & Application
3.7 Global Veterinary Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Veterinary Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Veterinary Vaccine Tier 1, Tier 2, and Tier
4 VETERINARY VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Veterinary Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Veterinary Vaccine Historic Market Size by Region
4.2.1 Global Veterinary Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Veterinary Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Veterinary Vaccine Forecasted Market Size by Region
4.3.1 Global Veterinary Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Veterinary Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 VETERINARY VACCINE BY APPLICATION
5.1 Veterinary Vaccine Market by Application
5.1.1 Livestock
5.1.2 Swine
5.1.3 Chicken
5.1.4 Dog & Cat
5.1.5 Others
5.2 Global Veterinary Vaccine Market Size by Application
5.2.1 Global Veterinary Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Veterinary Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Veterinary Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Veterinary Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Veterinary Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Veterinary Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Merck
6.1.1 Merck Comapny Information
6.1.2 Merck Business Overview
6.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Veterinary Vaccine Product Portfolio
6.1.5 Merck Recent Developments
6.2 Zoetis
6.2.1 Zoetis Comapny Information
6.2.2 Zoetis Business Overview
6.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Veterinary Vaccine Product Portfolio
6.2.5 Zoetis Recent Developments
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Comapny Information
6.3.2 Boehringer Ingelheim Business Overview
6.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments
6.4 Ceva
6.4.1 Ceva Comapny Information
6.4.2 Ceva Business Overview
6.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Veterinary Vaccine Product Portfolio
6.4.5 Ceva Recent Developments
6.5 CAHIC
6.5.1 CAHIC Comapny Information
6.5.2 CAHIC Business Overview
6.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CAHIC Veterinary Vaccine Product Portfolio
6.5.5 CAHIC Recent Developments
6.6 HVRI
6.6.1 HVRI Comapny Information
6.6.2 HVRI Business Overview
6.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HVRI Veterinary Vaccine Product Portfolio
6.6.5 HVRI Recent Developments
6.7 Ringpu Biology
6.7.1 Ringpu Biology Comapny Information
6.7.2 Ringpu Biology Business Overview
6.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
6.7.5 Ringpu Biology Recent Developments
6.8 Yebio
6.8.1 Yebio Comapny Information
6.8.2 Yebio Business Overview
6.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Yebio Veterinary Vaccine Product Portfolio
6.8.5 Yebio Recent Developments
6.9 DHN
6.9.1 DHN Comapny Information
6.9.2 DHN Business Overview
6.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 DHN Veterinary Vaccine Product Portfolio
6.9.5 DHN Recent Developments
6.10 WINSUN
6.10.1 WINSUN Comapny Information
6.10.2 WINSUN Business Overview
6.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 WINSUN Veterinary Vaccine Product Portfolio
6.10.5 WINSUN Recent Developments
6.11 Elanco
6.11.1 Elanco Comapny Information
6.11.2 Elanco Business Overview
6.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Elanco Veterinary Vaccine Product Portfolio
6.11.5 Elanco Recent Developments
6.12 Virbac
6.12.1 Virbac Comapny Information
6.12.2 Virbac Business Overview
6.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Virbac Veterinary Vaccine Product Portfolio
6.12.5 Virbac Recent Developments
6.13 Jinyu Bio-Technology
6.13.1 Jinyu Bio-Technology Comapny Information
6.13.2 Jinyu Bio-Technology Business Overview
6.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
6.13.5 Jinyu Bio-Technology Recent Developments
6.14 ChengDu Tecbond
6.14.1 ChengDu Tecbond Comapny Information
6.14.2 ChengDu Tecbond Business Overview
6.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
6.14.5 ChengDu Tecbond Recent Developments
6.15 CAVAC
6.15.1 CAVAC Comapny Information
6.15.2 CAVAC Business Overview
6.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CAVAC Veterinary Vaccine Product Portfolio
6.15.5 CAVAC Recent Developments
6.16 Kyoto Biken Laboratories
6.16.1 Kyoto Biken Laboratories Comapny Information
6.16.2 Kyoto Biken Laboratories Business Overview
6.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
6.16.5 Kyoto Biken Laboratories Recent Developments
6.17 FATRO
6.17.1 FATRO Comapny Information
6.17.2 FATRO Business Overview
6.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 FATRO Veterinary Vaccine Product Portfolio
6.17.5 FATRO Recent Developments
6.18 Vaksindo
6.18.1 Vaksindo Comapny Information
6.18.2 Vaksindo Business Overview
6.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Vaksindo Veterinary Vaccine Product Portfolio
6.18.5 Vaksindo Recent Developments
6.19 Bio-Labs
6.19.1 Bio-Labs Comapny Information
6.19.2 Bio-Labs Business Overview
6.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
6.19.5 Bio-Labs Recent Developments
6.20 Avimex Animal Health
6.20.1 Avimex Animal Health Comapny Information
6.20.2 Avimex Animal Health Business Overview
6.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
6.20.5 Avimex Animal Health Recent Developments
6.21 MEVAC
6.21.1 MEVAC Comapny Information
6.21.2 MEVAC Business Overview
6.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 MEVAC Veterinary Vaccine Product Portfolio
6.21.5 MEVAC Recent Developments
6.22 Biovac
6.22.1 Biovac Comapny Information
6.22.2 Biovac Business Overview
6.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Biovac Veterinary Vaccine Product Portfolio
6.22.5 Biovac Recent Developments
6.23 Atafen
6.23.1 Atafen Comapny Information
6.23.2 Atafen Business Overview
6.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Atafen Veterinary Vaccine Product Portfolio
6.23.5 Atafen Recent Developments
6.24 Dyntec
6.24.1 Dyntec Comapny Information
6.24.2 Dyntec Business Overview
6.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Dyntec Veterinary Vaccine Product Portfolio
6.24.5 Dyntec Recent Developments
6.25 BioTestLab
6.25.1 BioTestLab Comapny Information
6.25.2 BioTestLab Business Overview
6.25.3 BioTestLab Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.25.4 BioTestLab Veterinary Vaccine Product Portfolio
6.25.5 BioTestLab Recent Developments
6.26 RVSRI
6.26.1 RVSRI Comapny Information
6.26.2 RVSRI Business Overview
6.26.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.26.4 RVSRI Veterinary Vaccine Product Portfolio
6.26.5 RVSRI Recent Developments
6.27 Medion
6.27.1 Medion Comapny Information
6.27.2 Medion Business Overview
6.27.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Medion Veterinary Vaccine Product Portfolio
6.27.5 Medion Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Veterinary Vaccine Sales by Country
7.1.1 North America Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Veterinary Vaccine Sales by Country (2019-2024)
7.1.3 North America Veterinary Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Veterinary Vaccine Market Size by Country
7.2.1 North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Veterinary Vaccine Market Size by Country (2019-2024)
7.2.3 North America Veterinary Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Veterinary Vaccine Sales by Country
8.1.1 Europe Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Veterinary Vaccine Sales by Country (2019-2024)
8.1.3 Europe Veterinary Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Veterinary Vaccine Market Size by Country
8.2.1 Europe Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Veterinary Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Veterinary Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Veterinary Vaccine Sales by Country
9.1.1 Asia-Pacific Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Veterinary Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Veterinary Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Veterinary Vaccine Market Size by Country
9.2.1 Asia-Pacific Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Veterinary Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Veterinary Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Veterinary Vaccine Sales by Country
10.1.1 Latin America Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Veterinary Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Veterinary Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Veterinary Vaccine Market Size by Country
10.2.1 Latin America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Veterinary Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Veterinary Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Veterinary Vaccine Sales by Country
11.1.1 Middle East and Africa Veterinary Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Veterinary Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Veterinary Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Veterinary Vaccine Market Size by Country
11.2.1 Middle East and Africa Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Veterinary Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Veterinary Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Veterinary Vaccine Value Chain Analysis
12.1.1 Veterinary Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Veterinary Vaccine Production Mode & Process
12.2 Veterinary Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Veterinary Vaccine Distributors
12.2.3 Veterinary Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of Live Attenuated Vaccines
Table 2. Major Company of Inactivated Vaccines
Table 3. Major Company of Others
Table 4. Global Veterinary Vaccine Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 6. Global Veterinary Vaccine Sales Market Share in Volume by Type (2019-2024)
Table 7. Global Veterinary Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 8. Global Veterinary Vaccine Sales Market Share in Value by Type (2019-2024)
Table 9. Global Veterinary Vaccine Price by Type (2019-2024) & (USD/Doses)
Table 10. Global Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
Table 11. Global Veterinary Vaccine Sales Market Share in Volume by Type (2025-2030)
Table 12. Global Veterinary Vaccine Sales by Type (2025-2030) & (US$ Million)
Table 13. Global Veterinary Vaccine Sales Market Share in Value by Type (2025-2030)
Table 14. Global Veterinary Vaccine Price by Type (2025-2030) & (USD/Doses)
Table 15. North America Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 16. North America Veterinary Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 17. Europe Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 18. Europe Veterinary Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 19. Asia-Pacific Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 20. Asia-Pacific Veterinary Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 21. Latin America Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 22. Latin America Veterinary Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 23. Middle East and Africa Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 24. Middle East and Africa Veterinary Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 25. Veterinary Vaccine Industry Trends
Table 26. Veterinary Vaccine Industry Drivers
Table 27. Veterinary Vaccine Industry Opportunities and Challenges
Table 28. Veterinary Vaccine Industry Restraints
Table 29. Global Veterinary Vaccine Sales Revenue by Company (US$ Million) & (2019-2024)
Table 30. Global Veterinary Vaccine Revenue Market Share by Company (2019-2024)
Table 31. Global Veterinary Vaccine Sales by Company (2019-2024) & (M Doses)
Table 32. Global Veterinary Vaccine Sales Share by Company (2019-2024)
Table 33. Global Veterinary Vaccine Market Price by Company (2019-2024) & (USD/Doses)
Table 34. Global Veterinary Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 35. Global Veterinary Vaccine Key Company Manufacturing Sites & Headquarters
Table 36. Global Veterinary Vaccine Company, Product Type & Application
Table 37. Global Veterinary Vaccine Company Commercialization Time
Table 38. Global Company Market Concentration Ratio (CR5 and HHI)
Table 39. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 40. Global Veterinary Vaccine Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Global Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
Table 42. Global Veterinary Vaccine Sales Market Share in Volume by Region (2019-2024)
Table 43. Global Veterinary Vaccine Sales by Region (2019-2024) & (US$ Million)
Table 44. Global Veterinary Vaccine Sales Market Share in Value by Region (2019-2024)
Table 45. Global Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 46. Global Veterinary Vaccine Sales by Region (2025-2030) & (M Doses)
Table 47. Global Veterinary Vaccine Sales Market Share in Volume by Region (2025-2030)
Table 48. Global Veterinary Vaccine Sales by Region (2025-2030) & (US$ Million)
Table 49. Global Veterinary Vaccine Sales Market Share in Value by Region (2025-2030)
Table 50. Global Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2025-2030)
Table 51. Global Veterinary Vaccine Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 52. Global Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 53. Global Veterinary Vaccine Sales Market Share in Volume by Application (2019-2024)
Table 54. Global Veterinary Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 55. Global Veterinary Vaccine Sales Market Share in Value by Application (2019-2024)
Table 56. Global Veterinary Vaccine Price by Application (2019-2024) & (USD/Doses)
Table 57. Global Veterinary Vaccine Sales by Application (2025-2030) & (M Doses)
Table 58. Global Veterinary Vaccine Sales Market Share in Volume by Application (2025-2030)
Table 59. Global Veterinary Vaccine Sales by Application (2025-2030) & (US$ Million)
Table 60. Global Veterinary Vaccine Sales Market Share in Value by Application (2025-2030)
Table 61. Global Veterinary Vaccine Price by Application (2025-2030) & (USD/Doses)
Table 62. North America Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 63. North America Veterinary Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 64. Europe Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 65. Europe Veterinary Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 66. Asia-Pacific Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 67. Asia-Pacific Veterinary Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 68. Latin America Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 69. Latin America Veterinary Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 70. Middle East and Africa Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 71. Middle East and Africa Veterinary Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 72. Merck Company Information
Table 73. Merck Business Overview
Table 74. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 75. Merck Veterinary Vaccine Product Portfolio
Table 76. Merck Recent Development
Table 77. Zoetis Company Information
Table 78. Zoetis Business Overview
Table 79. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 80. Zoetis Veterinary Vaccine Product Portfolio
Table 81. Zoetis Recent Development
Table 82. Boehringer Ingelheim Company Information
Table 83. Boehringer Ingelheim Business Overview
Table 84. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 85. Boehringer Ingelheim Veterinary Vaccine Product Portfolio
Table 86. Boehringer Ingelheim Recent Development
Table 87. Ceva Company Information
Table 88. Ceva Business Overview
Table 89. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 90. Ceva Veterinary Vaccine Product Portfolio
Table 91. Ceva Recent Development
Table 92. CAHIC Company Information
Table 93. CAHIC Business Overview
Table 94. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 95. CAHIC Veterinary Vaccine Product Portfolio
Table 96. CAHIC Recent Development
Table 97. HVRI Company Information
Table 98. HVRI Business Overview
Table 99. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 100. HVRI Veterinary Vaccine Product Portfolio
Table 101. HVRI Recent Development
Table 102. Ringpu Biology Company Information
Table 103. Ringpu Biology Business Overview
Table 104. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 105. Ringpu Biology Veterinary Vaccine Product Portfolio
Table 106. Ringpu Biology Recent Development
Table 107. Yebio Company Information
Table 108. Yebio Business Overview
Table 109. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 110. Yebio Veterinary Vaccine Product Portfolio
Table 111. Yebio Recent Development
Table 112. DHN Company Information
Table 113. DHN Business Overview
Table 114. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 115. DHN Veterinary Vaccine Product Portfolio
Table 116. DHN Recent Development
Table 117. WINSUN Company Information
Table 118. WINSUN Business Overview
Table 119. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 120. WINSUN Veterinary Vaccine Product Portfolio
Table 121. WINSUN Recent Development
Table 122. Elanco Company Information
Table 123. Elanco Business Overview
Table 124. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 125. Elanco Veterinary Vaccine Product Portfolio
Table 126. Elanco Recent Development
Table 127. Virbac Company Information
Table 128. Virbac Business Overview
Table 129. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 130. Virbac Veterinary Vaccine Product Portfolio
Table 131. Virbac Recent Development
Table 132. Jinyu Bio-Technology Company Information
Table 133. Jinyu Bio-Technology Business Overview
Table 134. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 135. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
Table 136. Jinyu Bio-Technology Recent Development
Table 137. ChengDu Tecbond Company Information
Table 138. ChengDu Tecbond Business Overview
Table 139. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 140. ChengDu Tecbond Veterinary Vaccine Product Portfolio
Table 141. ChengDu Tecbond Recent Development
Table 142. CAVAC Company Information
Table 143. CAVAC Business Overview
Table 144. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 145. CAVAC Veterinary Vaccine Product Portfolio
Table 146. CAVAC Recent Development
Table 147. Kyoto Biken Laboratories Company Information
Table 148. Kyoto Biken Laboratories Business Overview
Table 149. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 150. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
Table 151. Kyoto Biken Laboratories Recent Development
Table 152. FATRO Company Information
Table 153. FATRO Business Overview
Table 154. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 155. FATRO Veterinary Vaccine Product Portfolio
Table 156. FATRO Recent Development
Table 157. Vaksindo Company Information
Table 158. Vaksindo Business Overview
Table 159. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 160. Vaksindo Veterinary Vaccine Product Portfolio
Table 161. Vaksindo Recent Development
Table 162. Bio-Labs Company Information
Table 163. Bio-Labs Business Overview
Table 164. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 165. Bio-Labs Veterinary Vaccine Product Portfolio
Table 166. Bio-Labs Recent Development
Table 167. Avimex Animal Health Company Information
Table 168. Avimex Animal Health Business Overview
Table 169. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 170. Avimex Animal Health Veterinary Vaccine Product Portfolio
Table 171. Avimex Animal Health Recent Development
Table 172. MEVAC Company Information
Table 173. MEVAC Business Overview
Table 174. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 175. MEVAC Veterinary Vaccine Product Portfolio
Table 176. MEVAC Recent Development
Table 177. Biovac Company Information
Table 178. Biovac Business Overview
Table 179. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 180. Biovac Veterinary Vaccine Product Portfolio
Table 181. Biovac Recent Development
Table 182. Atafen Company Information
Table 183. Atafen Business Overview
Table 184. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 185. Atafen Veterinary Vaccine Product Portfolio
Table 186. Atafen Recent Development
Table 187. Dyntec Company Information
Table 188. Dyntec Business Overview
Table 189. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 190. Dyntec Veterinary Vaccine Product Portfolio
Table 191. Dyntec Recent Development
Table 192. BioTestLab Company Information
Table 193. BioTestLab Business Overview
Table 194. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 195. BioTestLab Veterinary Vaccine Product Portfolio
Table 196. BioTestLab Recent Development
Table 197. RVSRI Company Information
Table 198. RVSRI Business Overview
Table 199. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 200. RVSRI Veterinary Vaccine Product Portfolio
Table 201. RVSRI Recent Development
Table 202. Medion Company Information
Table 203. Medion Business Overview
Table 204. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 205. Medion Veterinary Vaccine Product Portfolio
Table 206. Medion Recent Development
Table 207. North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 208. North America Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 209. North America Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 210. North America Veterinary Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 211. North America Veterinary Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 212. North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 213. North America Veterinary Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 214. North America Veterinary Vaccine Market Share by Country (2019-2024)
Table 215. North America Veterinary Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 216. North America Veterinary Vaccine Market Share Forecast by Country (2025-2030)
Table 217. Europe Veterin
Table 1. Major Company of Live Attenuated Vaccines
Table 2. Major Company of Inactivated Vaccines
Table 3. Major Company of Others
Table 4. Global Veterinary Vaccine Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 6. Global Veterinary Vaccine Sales Market Share in Volume by Type (2019-2024)
Table 7. Global Veterinary Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 8. Global Veterinary Vaccine Sales Market Share in Value by Type (2019-2024)
Table 9. Global Veterinary Vaccine Price by Type (2019-2024) & (USD/Doses)
Table 10. Global Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
Table 11. Global Veterinary Vaccine Sales Market Share in Volume by Type (2025-2030)
Table 12. Global Veterinary Vaccine Sales by Type (2025-2030) & (US$ Million)
Table 13. Global Veterinary Vaccine Sales Market Share in Value by Type (2025-2030)
Table 14. Global Veterinary Vaccine Price by Type (2025-2030) & (USD/Doses)
Table 15. North America Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 16. North America Veterinary Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 17. Europe Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 18. Europe Veterinary Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 19. Asia-Pacific Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 20. Asia-Pacific Veterinary Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 21. Latin America Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 22. Latin America Veterinary Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 23. Middle East and Africa Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 24. Middle East and Africa Veterinary Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 25. Veterinary Vaccine Industry Trends
Table 26. Veterinary Vaccine Industry Drivers
Table 27. Veterinary Vaccine Industry Opportunities and Challenges
Table 28. Veterinary Vaccine Industry Restraints
Table 29. Global Veterinary Vaccine Sales Revenue by Company (US$ Million) & (2019-2024)
Table 30. Global Veterinary Vaccine Revenue Market Share by Company (2019-2024)
Table 31. Global Veterinary Vaccine Sales by Company (2019-2024) & (M Doses)
Table 32. Global Veterinary Vaccine Sales Share by Company (2019-2024)
Table 33. Global Veterinary Vaccine Market Price by Company (2019-2024) & (USD/Doses)
Table 34. Global Veterinary Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 35. Global Veterinary Vaccine Key Company Manufacturing Sites & Headquarters
Table 36. Global Veterinary Vaccine Company, Product Type & Application
Table 37. Global Veterinary Vaccine Company Commercialization Time
Table 38. Global Company Market Concentration Ratio (CR5 and HHI)
Table 39. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 40. Global Veterinary Vaccine Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Global Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
Table 42. Global Veterinary Vaccine Sales Market Share in Volume by Region (2019-2024)
Table 43. Global Veterinary Vaccine Sales by Region (2019-2024) & (US$ Million)
Table 44. Global Veterinary Vaccine Sales Market Share in Value by Region (2019-2024)
Table 45. Global Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 46. Global Veterinary Vaccine Sales by Region (2025-2030) & (M Doses)
Table 47. Global Veterinary Vaccine Sales Market Share in Volume by Region (2025-2030)
Table 48. Global Veterinary Vaccine Sales by Region (2025-2030) & (US$ Million)
Table 49. Global Veterinary Vaccine Sales Market Share in Value by Region (2025-2030)
Table 50. Global Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2025-2030)
Table 51. Global Veterinary Vaccine Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 52. Global Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 53. Global Veterinary Vaccine Sales Market Share in Volume by Application (2019-2024)
Table 54. Global Veterinary Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 55. Global Veterinary Vaccine Sales Market Share in Value by Application (2019-2024)
Table 56. Global Veterinary Vaccine Price by Application (2019-2024) & (USD/Doses)
Table 57. Global Veterinary Vaccine Sales by Application (2025-2030) & (M Doses)
Table 58. Global Veterinary Vaccine Sales Market Share in Volume by Application (2025-2030)
Table 59. Global Veterinary Vaccine Sales by Application (2025-2030) & (US$ Million)
Table 60. Global Veterinary Vaccine Sales Market Share in Value by Application (2025-2030)
Table 61. Global Veterinary Vaccine Price by Application (2025-2030) & (USD/Doses)
Table 62. North America Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 63. North America Veterinary Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 64. Europe Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 65. Europe Veterinary Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 66. Asia-Pacific Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 67. Asia-Pacific Veterinary Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 68. Latin America Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 69. Latin America Veterinary Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 70. Middle East and Africa Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 71. Middle East and Africa Veterinary Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 72. Merck Company Information
Table 73. Merck Business Overview
Table 74. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 75. Merck Veterinary Vaccine Product Portfolio
Table 76. Merck Recent Development
Table 77. Zoetis Company Information
Table 78. Zoetis Business Overview
Table 79. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 80. Zoetis Veterinary Vaccine Product Portfolio
Table 81. Zoetis Recent Development
Table 82. Boehringer Ingelheim Company Information
Table 83. Boehringer Ingelheim Business Overview
Table 84. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 85. Boehringer Ingelheim Veterinary Vaccine Product Portfolio
Table 86. Boehringer Ingelheim Recent Development
Table 87. Ceva Company Information
Table 88. Ceva Business Overview
Table 89. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 90. Ceva Veterinary Vaccine Product Portfolio
Table 91. Ceva Recent Development
Table 92. CAHIC Company Information
Table 93. CAHIC Business Overview
Table 94. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 95. CAHIC Veterinary Vaccine Product Portfolio
Table 96. CAHIC Recent Development
Table 97. HVRI Company Information
Table 98. HVRI Business Overview
Table 99. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 100. HVRI Veterinary Vaccine Product Portfolio
Table 101. HVRI Recent Development
Table 102. Ringpu Biology Company Information
Table 103. Ringpu Biology Business Overview
Table 104. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 105. Ringpu Biology Veterinary Vaccine Product Portfolio
Table 106. Ringpu Biology Recent Development
Table 107. Yebio Company Information
Table 108. Yebio Business Overview
Table 109. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 110. Yebio Veterinary Vaccine Product Portfolio
Table 111. Yebio Recent Development
Table 112. DHN Company Information
Table 113. DHN Business Overview
Table 114. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 115. DHN Veterinary Vaccine Product Portfolio
Table 116. DHN Recent Development
Table 117. WINSUN Company Information
Table 118. WINSUN Business Overview
Table 119. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 120. WINSUN Veterinary Vaccine Product Portfolio
Table 121. WINSUN Recent Development
Table 122. Elanco Company Information
Table 123. Elanco Business Overview
Table 124. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 125. Elanco Veterinary Vaccine Product Portfolio
Table 126. Elanco Recent Development
Table 127. Virbac Company Information
Table 128. Virbac Business Overview
Table 129. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 130. Virbac Veterinary Vaccine Product Portfolio
Table 131. Virbac Recent Development
Table 132. Jinyu Bio-Technology Company Information
Table 133. Jinyu Bio-Technology Business Overview
Table 134. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 135. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
Table 136. Jinyu Bio-Technology Recent Development
Table 137. ChengDu Tecbond Company Information
Table 138. ChengDu Tecbond Business Overview
Table 139. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 140. ChengDu Tecbond Veterinary Vaccine Product Portfolio
Table 141. ChengDu Tecbond Recent Development
Table 142. CAVAC Company Information
Table 143. CAVAC Business Overview
Table 144. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 145. CAVAC Veterinary Vaccine Product Portfolio
Table 146. CAVAC Recent Development
Table 147. Kyoto Biken Laboratories Company Information
Table 148. Kyoto Biken Laboratories Business Overview
Table 149. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 150. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
Table 151. Kyoto Biken Laboratories Recent Development
Table 152. FATRO Company Information
Table 153. FATRO Business Overview
Table 154. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 155. FATRO Veterinary Vaccine Product Portfolio
Table 156. FATRO Recent Development
Table 157. Vaksindo Company Information
Table 158. Vaksindo Business Overview
Table 159. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 160. Vaksindo Veterinary Vaccine Product Portfolio
Table 161. Vaksindo Recent Development
Table 162. Bio-Labs Company Information
Table 163. Bio-Labs Business Overview
Table 164. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 165. Bio-Labs Veterinary Vaccine Product Portfolio
Table 166. Bio-Labs Recent Development
Table 167. Avimex Animal Health Company Information
Table 168. Avimex Animal Health Business Overview
Table 169. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 170. Avimex Animal Health Veterinary Vaccine Product Portfolio
Table 171. Avimex Animal Health Recent Development
Table 172. MEVAC Company Information
Table 173. MEVAC Business Overview
Table 174. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 175. MEVAC Veterinary Vaccine Product Portfolio
Table 176. MEVAC Recent Development
Table 177. Biovac Company Information
Table 178. Biovac Business Overview
Table 179. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 180. Biovac Veterinary Vaccine Product Portfolio
Table 181. Biovac Recent Development
Table 182. Atafen Company Information
Table 183. Atafen Business Overview
Table 184. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 185. Atafen Veterinary Vaccine Product Portfolio
Table 186. Atafen Recent Development
Table 187. Dyntec Company Information
Table 188. Dyntec Business Overview
Table 189. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 190. Dyntec Veterinary Vaccine Product Portfolio
Table 191. Dyntec Recent Development
Table 192. BioTestLab Company Information
Table 193. BioTestLab Business Overview
Table 194. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 195. BioTestLab Veterinary Vaccine Product Portfolio
Table 196. BioTestLab Recent Development
Table 197. RVSRI Company Information
Table 198. RVSRI Business Overview
Table 199. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 200. RVSRI Veterinary Vaccine Product Portfolio
Table 201. RVSRI Recent Development
Table 202. Medion Company Information
Table 203. Medion Business Overview
Table 204. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 205. Medion Veterinary Vaccine Product Portfolio
Table 206. Medion Recent Development
Table 207. North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 208. North America Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 209. North America Veterinary Vaccine Sales Market Share by Country (2019-2024)
Table 210. North America Veterinary Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 211. North America Veterinary Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 212. North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 213. North America Veterinary Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 214. North America Veterinary Vaccine Market Share by Country (2019-2024)
Table 215. North America Veterinary Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 216. North America Veterinary Vaccine Market Share Forecast by Country (2025-2030)
Table 217. Europe Veterin
